Economic Evaluations in Electrophysiology in the Last 15 Years: A Systematic Review of the Literature
- PMID: 40351680
- PMCID: PMC12059752
- DOI: 10.31083/RCM36206
Economic Evaluations in Electrophysiology in the Last 15 Years: A Systematic Review of the Literature
Abstract
Background: Electrophysiology (EP) procedures, including cardiac implantable electronic devices (CIEDs) and ablations, are widely used to manage arrhythmias and heart failure. These interventions, though effective, require substantial resources, prompting the need for systematic economic evaluations to inform healthcare decision-making.
Methods: A systematic review of studies from 2007 to 2024 was conducted in two phases. Phase one assessed trends in economic evaluations of EP procedures, analyzing 129 studies across regions and timeframes. Phase two focused on cost-effectiveness analyses of implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy defibrillators (CRT-Ds), and atrial fibrillation (AF) ablation, examining outcomes like quality-adjusted life years (QALYs) and incremental cost-effectiveness ratios (ICERs), while identifying factors influencing economic results.
Results: EP procedures generally demonstrated favorable cost-effectiveness, particularly in high-income regions. Studies on ICDs and CRT-Ds consistently supported their economic value for patients with arrhythmias or heart failure, while AF ablation showed potential for long-term benefits, particularly when compared to medical therapies. However, results varied by region, reflecting differences in healthcare systems, costs, and patient populations.
Conclusions: The review highlights the overall cost-effectiveness of EP procedures in many settings but underscores the need for tailored economic evaluations in low- and middle-income countries. Simplified methodologies and greater attention to regional contexts are recommended to guide resource allocation and policy development globally.
Keywords: ablation; atrial fibrillation; cost-effectiveness; defibrillator; health economics; pacemaker.
Copyright: © 2025 The Author(s). Published by IMR Press.
Conflict of interest statement
The authors declare no conflict of interest. GB reported small speaker fees from Bayer, Boehringer Ingelheim, Boston, Daiichi Sankyo, Janssen, and Sanofi outside of the submitted work. GB is also the Principal Investigator of the ARISTOTELES project (Applying ARtificial Intelligence to define clinical trajectorieS for personalized predicTiOn and early deTEction of comorbidity and muLtimorbidity pattErnS), funded by the European Union within the Horizon 2020 research and innovation program (Grant No. 101080189). LO received funding from the European Union for collaboration in the ASSESS DHT project (grant number 101137347) and has received speaker fees for a consulting contract with Eli Lilly and Company. RCA has received small honoraria for educational meetings from Abbott and Boston Scientific. All other authors report no disclosures. Ruben Casado-Arroyo and Giuseppe Boriani are serving as the Editorial Board members of this journal. We declare that Ruben Casado-Arroyo and Giuseppe Boriani had no involvement in the peer review of this article and have no access to information regarding its peer review. Full responsibility for the editorial process for this article was delegated to Yong Peng.
Figures




Similar articles
-
Economic Considerations of Cardiovascular Implantable Electronic Devices for The Treatment of Heart Failure.Curr Heart Fail Rep. 2024 Jun;21(3):186-193. doi: 10.1007/s11897-024-00664-y. Epub 2024 Apr 25. Curr Heart Fail Rep. 2024. PMID: 38662154 Review.
-
Remote Monitoring of Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy and Permanent Pacemakers: A Health Technology Assessment.Ont Health Technol Assess Ser. 2018 Oct 24;18(7):1-199. eCollection 2018. Ont Health Technol Assess Ser. 2018. PMID: 30443279 Free PMC article. Review.
-
Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.Ont Health Technol Assess Ser. 2005;5(14):1-74. Epub 2005 Sep 1. Ont Health Technol Assess Ser. 2005. PMID: 23074465 Free PMC article.
-
Advanced electrophysiologic mapping systems: an evidence-based analysis.Ont Health Technol Assess Ser. 2006;6(8):1-101. Epub 2006 Mar 1. Ont Health Technol Assess Ser. 2006. PMID: 23074499 Free PMC article.
-
A review of economic evaluation models for cardiac resynchronization therapy with implantable cardioverter defibrillators in patients with heart failure.Eur J Health Econ. 2016 Dec;17(9):1159-1172. doi: 10.1007/s10198-015-0752-3. Epub 2016 Jan 4. Eur J Health Econ. 2016. PMID: 26728985 Free PMC article. Review.
Cited by
-
Cost-effectiveness of an intraoperative antibacterial envelope in preventing cardiac implantable device-associated infections: a systematic review.Europace. 2025 Jul 1;27(7):euaf121. doi: 10.1093/europace/euaf121. Europace. 2025. PMID: 40519051 Free PMC article. Review.
References
-
- Van Gelder IC, Rienstra M, Bunting KV, Casado-Arroyo R, Caso V, Crijns HJGM, et al. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) European Heart Journal . 2024;45:3314–3414. doi: 10.1093/eurheartj/ehae176. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials